Home / Recalls / Advanced Nutriceuticals, LLC / D-0128-2021

D-0128-2021 Class II Ongoing

Recalled by Advanced Nutriceuticals, LLC — Indianapolis, IN

Recall Details

Product Type
Drugs
Report Date
December 23, 2020
Initiation Date
November 30, 2020
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6 vials

Product Description

CJC-1295, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Reason for Recall

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Distribution Pattern

CA, CO, FL, IN, KY, OH, TX

Code Information

Lot #1029202004, Exp 11/29/2020; Lot #1102202001, 102202009, Exp 12/08/2020; Lot #1105202009, Exp 12/20/2020; Lot #1110202003, Exp 12/10/2020; Lot #1112202004, Exp 12/12/2020

Other recalls by Advanced Nutriceuticals, LLC

  • D-0133-2021 Class II — THYMOSIN ALPHA, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicin (November 30, 2020)
  • D-0139-2021 Class II — CEREBROLYSIN, 107.5 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine (November 30, 2020)
  • D-0132-2021 Class II — BPC-157, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indi (November 30, 2020)
  • D-0140-2021 Class II — THYMOSIN BETA - 4, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medi (November 30, 2020)
  • D-0141-2021 Class II — GHK-CU, 10 MG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianap (November 30, 2020)
  • D-0142-2021 Class II — HIGH DOSE B12, 10 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, (November 30, 2020)
  • D-0129-2021 Class II — FGL, 10 MG/ML, 3 ML vial, The Guyer Institute of Molecular Medicine, Indianapoli (November 30, 2020)
  • D-0135-2021 Class II — GHRP, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indiana (November 30, 2020)
  • D-0143-2021 Class II — LL-37, 2000 MCG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Indian (November 30, 2020)
  • D-0137-2021 Class II — B12 for Injection, 2 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicin (November 30, 2020)